EspeRare being featured on 'Objectif croissance' program, France

 Our R&D Director, Florence Porte-Thomé was recently featured in an engaging interview on the 'Objectif croissance' program, where she presented EspeRare's "venture philanthropy" model and cutting-edge innovations in drug development for rare diseases. The discussion was vibrant and inspiring, highlighting EspeRare's commitment to transforming lives through science.

More insights and the full interview coming soon.